We are in the process of upgrading our site. Please kindly cooperate with us.

Published Articles

215,213

Total Articles

285,213

Happy users

1,459,539

Open Access JournalsView More

Medical

Editors-in-Chief View More

Journal of Chemistry: Education Research and Practice
Rodrigo Rodolfo Gonz, PhD
Editor-in-Chief
Professor, ournal of Chemistry: Education Research and Practice(JCERP)
Benemérita Universidad Autónoma de Puebla, Puebla, Mexico
International Journal of Orthopaedics Research
Daniel R Schlatterer
Editor-in-Chief
Director, Department of Orthopedic Surgery
Wellstar at Atlanta Medical Center, USA
Journal of Genetic Engineering and Biotechnology Research
Dr. Md Mahmudul Hasan Khan, PhD
Editor-in-Chief
Scientist (Scientific officer), Genetics and Breeding
Universiti Putra Malaysia (UPM), Malaysia, SELANGOR, Malaysia
Journal of Applied Engineering Education
DR ADIL HAKEEM KHAN, MBA PhD
Editor-in-Chief
DIRECTOR, RESEARCH
Aeero (Aarav Educational & Employment Research Organization) (Affiliated by Guru GobindSingh Indraprastha University Dwarka, New Delhi.), Dwarka, New Delhi India, DELHI, India
Journal of Clinical Review & Case Reports
Sangeeta Singg, PhD, LP, ACN
Editor-in-Chief
Professor, Department of Psychology
Former President of Psychological Association of Greater West Texas, USA
Political Science International
Osaretin Idahosa, Ph.D
Editor-in-Chief
Professor, Department of Political Science
University of Benin, Benin City, Edo State, Nigeria

Latest Articles from "Opast Publisher"

Research Article     Free Accress

Is Sentinel Lymph Node Tumor Burden a Prognostic Factor for Disease-Free Survival in Patients with Melanoma of the Trunk and Extremities?

Carlos Lehmann-Mosquera, Raul Suarez-Rodriguez, Patricia Lopez-Correa, Ricardo Sanchez, Samuel David Morales, Mau-ricio Garcia-Mora, Javier Angel-Aristizabal, Ivan Marino-Lozano, Carlos Alfonso Duarte-Torres and Sandra E. Diaz-Casas

International Journal of Cancer Research & Therapy

Research Article     Free Accress

Is Sentinel Lymph Node Tumor Burden a Prognostic Factor for Disease-Free Survival in Patients with Melanoma of the Trunk and Extremities?

Carlos Lehmann-Mosquera, Raul Suarez-Rodriguez, Patricia Lopez-Correa, Ricardo Sanchez, Samuel David Morales, Mau-ricio Garcia-Mora, Javier Angel-Aristizabal, Ivan Marino-Lozano, Carlos Alfonso Duarte-Torres and Sandra E. Diaz-Casas

International Journal of Cancer Research & Therapy

Research Article     Free Accress

Outcomes of Brentuximab Vedotin with or without Bendamustine and Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma: An Early Experience from Patient Access Programme in India

Jyothi Goutham, Samrudhi Joshi, Shekar Patil, Satheesh Chiradoni Thungappa, Ravi Thippeswamy, Shashidha-ra HP, Nishit Ojha, Amey C Panchal, Yesheswini N Naik, Jayantha Balawardane and Sachin Suresh Jadhav

Advances in Hematology and Oncology Research

Research Article     Free Accress

Outcomes of Brentuximab Vedotin with or without Bendamustine and Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma: An Early Experience from Patient Access Programme in India

Jyothi Goutham, Samrudhi Joshi, Shekar Patil, Satheesh Chiradoni Thungappa, Ravi Thippeswamy, Shashidha-ra HP, Nishit Ojha, Amey C Panchal, Yesheswini N Naik, Jayantha Balawardane and Sachin Suresh Jadhav

Advances in Hematology and Oncology Research

List of Pubmed Articles